Species distribution and antifungal susceptibilities of bloodstream Candida isolates: a nine-years single center survey

J Chemother. 2020 Sep;32(5):244-250. doi: 10.1080/1120009X.2020.1783154. Epub 2020 Jun 25.

Abstract

This study analyzed the epidemiology of bloodstream infections due to Candida spp. in a tertiary referral hospital of Ancona, Italy, and their susceptibility to antifungals. The retrospective observational study from January 2010 to December 2018 identified 504 episodes of candidemia in 461 patients. Although Candida albicans remained the species most frequently isolated, Candida spp. other than C. albicans caused 49% of the overall episodes of candidemia. According to CLSI interpretation, most of the isolates resulted susceptible to antifungals. Azoles vs Candida tropicalis represented an exception. Echinocandin non-susceptibility was rare across the species. In conclusion, with the exception of C. tropicalis, the isolation of a non-susceptible Candida strains against azoles, echinocandins and amphotericin B was a rare event.

Keywords: Candida species; antifungal resistance; antifungal susceptibility testing; antifungal therapy; bloodstream infections; candidemia; fungal infections.

Publication types

  • Clinical Trial
  • Observational Study

MeSH terms

  • Aged
  • Antifungal Agents / pharmacology*
  • Blood Culture / methods*
  • Candida / classification*
  • Candida / drug effects
  • Candida / isolation & purification*
  • Candidemia / drug therapy
  • Candidemia / epidemiology*
  • Candidemia / microbiology
  • Female
  • Humans
  • Italy / epidemiology
  • Male
  • Middle Aged
  • Retrospective Studies

Substances

  • Antifungal Agents